Want to join the conversation?
$MCUR to merge with Leap Therapeutics. The combined entity's leadership team will consist of Christopher Mirabelli, who will serve as CEO and Chairman of the BoD, Augustine Lawlor as COO, and Douglas Onsi as CFO. At the closing, two $MCUR designated individuals, including Nissim Mashiach, will join Leap's BoD.
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.